Anti-CV was tested in 77 uremic patients, 48 on hemodialysis (HD), 29 on CAPD, by immunoenzymatic 1st and 2nd generation assays (ELISA I, II) and 4-antigen (4-RIBA) immublotting.
The investigation was extended to the staff (n=29) and to HCV-positive patients' families (n=30).
The prevalence using 2nd generation tests was double (21%) that in 1st generation tests (11%). A greater incidence in the HD than in the CAPD group (23 vs. 17%) and a highly significative correlation to dialytic age were observed.
Mots-clés Pascal : Hémodialyse, Epuration extrarénale, Réanimation, Appareil urinaire pathologie, Homme, Prévalence, Anticorps, Virus hépatite C, Virus, Facteur risque, Epidémiologie
Mots-clés Pascal anglais : Hemodialysis, Extrarenal dialysis, Resuscitation, Urinary system disease, Human, Prevalence, Antibody, Hepatitis C virus, Virus, Risk factor, Epidemiology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 92-0392091
Code Inist : 002B27B03. Création : 199406.